uniQure Announces FDA Breakthrough Therapy Designation for AMT-060 in Hemophilia B
Jan 30, 2017 12:00 pm UTC| Business
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Jan. 30, 2017 -- uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today announced that AMT-060, its proprietary, investigational gene therapyin patients with...
Prospect Capital Schedules Second Quarter Earnings Release and Conference Call
Jan 30, 2017 12:00 pm UTC| Business
NEW YORK, Jan. 30, 2017 -- Prospect Capital Corporation (NASDAQ:PSEC) (“Company”) announced today that it expects to file with the Securities and Exchange Commission its report on Form 10-Q containing its second fiscal...
Tandy Leather Factory Announces Reopening of Store in Harrisburg, PA
Jan 30, 2017 12:00 pm UTC| Business
FORT WORTH, Texas, Jan. 30, 2017 -- Tandy Leather Factory, Inc. (NASDAQ:TLF) today announced that it is reopening its store in Harrisburg, PA. The store was closed in April 2016 and is reopening in a new location...
GW Pharmaceuticals to Report Q1 Financial Results and Host Conference Call on 7 February, 2017
Jan 30, 2017 12:00 pm UTC| Business
LONDON, Jan. 30, 2017 -- GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary...
Zomedica Announces Two Transdermal Products for Cats
Jan 30, 2017 11:55 am UTC| Business
ANN ARBOR, Mich., Jan. 30, 2017 -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical and health care solutions company, today announced that it opened its fourth Investigational New Animal Drug...

Amazon May Hire 100,000 More Employees from the US by the End of Q2, 2018
Jan 30, 2017 11:50 am UTC| Business
Ecommerce giant Amazon currently has 180,000 US employees working for it and the company is looking to increase that number by as much as 100,000 by the end of Q2, 2018. The 55% increase in employees within the US would...
Jan 30, 2017 11:45 am UTC| Business
Incyte gains worldwide rights to CB-1158 for hematology and oncology indicationsCalithera to receive a $45 million up-front payment and an $8 million equity investmentIncyte and Calithera to co-fund global development of...